June 14, 2022
Life Sciences
  • Senator Amy Klobuchar and Representative Katie Porter asked the Federal Trade Commission (FTC) to investigate whether Janssen Pharmaceuticals and Bristol Myers Squibb Co. coordinated “parallel” price increases on Xarelto and Eliquis. The letter noted that, the blood-thinner drugs are “close substitutes for each other” and that the prices for the drugs more than doubled over the past 10 years. (Article here)